Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy
Early and precise delineation of therapeutic responses are key issues in NEN/tumor management. Imaging is currently used but exhibits limitations in sensitivity and specificity. NETest values (80 –100%) were more accurate and occurred at a significantly earlier
time point than CgA and predicted SSA treatment response.